BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rivas-Ramírez ÁR, Tendilla-Beltrán H, Gómez-Mendoza LE, Loaiza G, Flores G. Patients with schizophrenia have decreased COVID-19 prevalence among hospitalised patients with psychiatric and neurological diseases: A retrospective analysis in Mexican population. Int J Clin Pract 2021;:e14528. [PMID: 34125988 DOI: 10.1111/ijcp.14528] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
Number Citing Articles
1 Tang SW, Leonard BE, Helmeste DM. Long COVID, neuropsychiatric disorders, psychotropics, present and future. Acta Neuropsychiatr 2022;34:109-26. [PMID: 35144718 DOI: 10.1017/neu.2022.6] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
2 Pardamean E, Roan W, Iskandar KTA, Prayangga R, Hariyanto TI. Mortality from coronavirus disease 2019 (Covid-19) in patients with schizophrenia: A systematic review, meta-analysis and meta-regression. General Hospital Psychiatry 2022. [DOI: 10.1016/j.genhosppsych.2022.01.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Rivas-Ramírez ÁR, Tendilla-Beltrán H, Gómez-Mendoza LE, Loaiza G, Flores G. Patients with schizophrenia have decreased COVID-19 prevalence among hospitalised patients with psychiatric and neurological diseases: A retrospective analysis in Mexican population. Int J Clin Pract 2021;:e14528. [PMID: 34125988 DOI: 10.1111/ijcp.14528] [Cited by in F6Publishing: 3] [Reference Citation Analysis]